The Aortic abdominal stent graft is used for abdominal aneurysm endovascular repair. Endovascular aneurysm repair (EVAR), is a new treatment option for abdominal aortic aneurysm in which a graft is inserted into the aorta to strengthen it. This surgery doesn’t need surgically opening the chest or abdomen and done using catheters.

The Abdominal aortic stents grafts market is projected to grow in near the future owing to the increasing prevalence of aortic aneurysm, increasing number of clinical trials, rising life expectancy rate, and adoption of minimally invasive surgeries. Additionally, there has been a paradigm shift towards EVAR from the open repair surgery due to its advantages (as the endovascular aneurysm repair is less invasive than open surgery, reduced length of stay in the hospital and reduced blood loss, and time under general anesthesia.

On the other hand, lack of trained healthcare providers and the risk of other complications regarding the aortic stent grafts may restrain the market growth.

The Global Abdominal aorta stent grafts market is segmented based on product type, end users, and region. Based on the product type, the market is divided into polymer and metal.

The market is segmented into hospitals, ambulatory surgical centers, and specialty clinics based on end users. Based on the region, the market is studied across North America, Asia Pacific, Europe, and LAMEA.

North America accounted for the largest share of the market in 2019, followed by Europe and Asia Pacific. On the other hand, the Asia Pacific is projected to have the highest growth rate during the forecast period.

The key players operating in the market include Bentley InnoMed, Bolton Medical, Braile Biomedica, COOK Medical, Cordis, Endologix, W. L. Gore, Jotec, Jotec GmbH, Lombard Medical, Medtronic, Shanghai Microport Orthopedics among others.